pharmacovigilance

R&D

Automation of literature search and review

Over the years, pharmacovigilance (PV) processes have relied on PV professionals manually sifting through large volumes of data to identify, assess, and report Adverse Event (AE) informatio

Digital

The future of pharmacovigilance – beginning the shift to AI-...

In 2023, the pharmaceutical industry saw a surge in innovation.

Digital

How technology is redefining pharmacovigilance

Big data, artificial intelligence (AI), and machine learning (ML) are driving a technological revolution in healthcare.

News

FDA launches wide probe into CAR-T therapy safety

The FDA has announced it will start an investigation into the safety of CAR-T therapies, after becoming concerned that they may be linked to the development of T-cell canc

Patients

12 Questions with Jenny Reid-Young

With 17+ years in Medical Information, Jenny Reid-Young excels in managing diverse, multilingual teams across Europe, Middle East, Africa, Asia-Pacific, and the Americas.

News

EMA finds no evidence GLP-1 agonists cause thyroid cancer

The EMA’s safety committee has said that, after a review of available data, it has found no evidence that GLP-1 agonist drugs such as Novo Nordisk’s Ozempic and Eli Lilly’